Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa. - Orlans HO; McClements ME; Barnard AR; Martinez-Fernandez de la Camara C; MacLaren RE (Nature communications, 2021)